Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.24 USD | -1.59% | +3.33% | +18.10% |
Mar. 19 | Aclaris Therapeutics, Inc. Announces Board Resignations | CI |
Feb. 27 | Aclaris Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Aclaris Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Aclaris Therapeutics, Inc.
HC Wainwright | |
BTIG | |
Stifel Nicolaus | |
Cantor Fitzgerald | |
Evercore ISI | |
William Blair & Co. | |
Piper Sandler | |
Goldman Sachs |
EPS Revisions
- Stock
- Equities
- Stock Aclaris Therapeutics, Inc. - Nasdaq
- Consensus Aclaris Therapeutics, Inc.